Dynavax Technologies Corporation was founded as an immunology-focused company in 1997 by Michael A. Ostrakhovsky, M.D., and Hasmukh P. Wani, Ph.D. The company went public in 2005 and is traded on the NASDAQ. Dynavax has licensed a number of technologies from the University of California and other academic and biopharmaceutical companies.
